As we close in to end 2020, a year that will be engraved in our memories forever, we are bound to remember an unexpected and unprecedented pandemic and a world that has had to reinvent the way we live, work and communicate. Yet, despite the challenges, and to the best of our ability, we have tried to find ways to cope.

For us at the Medicines Patent Pool (MPP), it has been 10 years since we started. A decade on and the work of MPP is more relevant than ever. At the beginning of the year, we had high hopes of celebrating our achievements by physically bringing you together with all our partners who have contributed to our impact, but COVID-19 had other plans! The pandemic threatened lives and livelihoods, but I can proudly say that this did not deter us, in fact it gave us a bigger reason to come together through our joint mission of leaving no one behind in the access to treatment landscape. In a swift and agile move, MPP’s Board expanded the organisation’s mandate to COVID-19 shortly after the pandemic was declared. Since then, we have not only been exploring how MPP’s proven model of voluntary licensing can make a difference to the COVID-19 response, but also been making sure that our work in HIV, hepatitis C, TB and essential medicines is not disrupted owing to the pandemic. So, if you think a lot has happened this year, let me take you back 10 years and more to a time when MPP was just an idea.